Anatara Lifesciences Ltd News

Anatara Lifesciences Ltd: Appendix 4C & Q4 FY24 Activities Report

Jul 29 22:40 ET

Anatara Lifesciences Ltd: Change of Director's Interest Notice

Jul 11 18:49 ET

Anatara Lifesciences Ltd: Notification regarding unquoted securities - ANR

Jul 10 19:47 ET

Anatara Lifesciences Ltd: Application for quotation of securities - ANR

Jul 9 00:32 ET

Anatara Lifesciences Ltd: Results of Meeting

Jul 5 01:01 ET

Anatara Lifesciences Ltd: IBS Clinical Trial Stage 2 recruitment is proceeding well

Jun 12 19:00 ET

Anatara Lifesciences Ltd: Notice of General Meeting/Proxy Form

Jun 2 19:47 ET

Anatara Lifesciences Ltd: ANR- Cleansing Notice

May 13 23:06 ET

Anatara Lifesciences Ltd: Notification regarding unquoted securities - ANR

May 6 21:55 ET

Anatara Lifesciences Ltd: Application for quotation of securities - ANR

May 6 21:39 ET

Anatara Lifesciences Ltd: Proposed issue of securities - ANR

Apr 30 20:15 ET

Anatara Lifesciences Ltd: Anatara successful placement for $1.0M

Apr 30 20:14 ET

Anatara Lifesciences Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29 20:08 ET

Anatara Lifesciences Ltd: Trading Halt

Apr 28 18:40 ET

Anatara Lifesciences Ltd: Change in substantial holding

Apr 22 00:53 ET

Anatara Lifesciences Ltd: Recruitment 5 sites for Pivotal IBS Clinical Trial Stage 2

Apr 8 19:56 ET

Anatara Lifesciences Ltd: Recruitment for Pivotal Phase II IBS Clinical Trial Stage 2

Feb 28 19:58 ET

Anatara Lifesciences Ltd: Appendix 4D & Half Year Report 31 December 2023

Feb 27 19:52 ET

Anatara Lifesciences Ltd: Appendix 4C & Q2 FY24 Activities Report

Jan 23 17:36 ET

Anatara Lifesciences Ltd: Cleansing Notice

Dec 18, 2023 01:26 ET